SCM
Silverarc Capital Management’s KalVista Pharmaceuticals KALV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.7M | Buy |
1,832,171
+133,187
| +8% | +$1.51M | 3.82% | 7 |
|
|
2025
Q1 | $19.6M | Buy |
1,698,984
+1,086,811
| +178% | +$12.5M | 4.01% | 6 |
|
|
2024
Q4 | $5.19M | Buy |
612,173
+37,615
| +7% | +$319K | 1.13% | 31 |
|
|
2024
Q3 | $6.65M | Buy |
574,558
+13,675
| +2% | +$158K | 1.49% | 20 |
|
|
2024
Q2 | $6.61M | Sell |
560,883
-300
| -0.1% | -$3.53K | 1.56% | 21 |
|
|
2024
Q1 | $6.66M | Buy |
561,183
+449,449
| +402% | +$5.33M | 1.85% | 20 |
|
|
2023
Q4 | $1.37M | Sell |
111,734
-117,200
| -51% | -$1.44M | 0.41% | 53 |
|
|
2023
Q3 | $2.2M | Sell |
228,934
-491,574
| -68% | -$4.73M | 0.67% | 36 |
|
|
2023
Q2 | $6.48M | Sell |
720,508
-3,036
| -0.4% | -$27.3K | 2.01% | 15 |
|
|
2023
Q1 | $5.69M | Buy |
+723,544
| New | +$5.69M | 2.35% | 15 |
|
|
2021
Q3 | – | Sell |
-14,882
| Closed | -$357 | – | 90 |
|
|
2021
Q2 | $357 | Sell |
14,882
-35,118
| -70% | -$842 | 0.16% | 81 |
|
|
2021
Q1 | $1.29M | Buy |
+50,000
| New | +$1.29M | 0.7% | 49 |
|